Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides
作者:Naoyuki Masuda、Osamu Yamamoto、Masahiro Fujii、Tetsuro Ohgami、Jiro Fujiyasu、Toru Kontani、Ayako Moritomo、Masaya Orita、Hiroyuki Kurihara、Hironobu Koga、Hideaki Nakahara、Shunji Kageyama、Mitsuaki Ohta、Hiroshi Inoue、Toshifumi Hatta、Hiroshi Suzuki、Kenji Sudo、Yasuaki Shimizu、Eiichi Kodama、Masao Matsuoka、Masatoshi Fujiwara、Tomoyuki Yokota、Shiro Shigeta、Masanori Baba
DOI:10.1016/j.bmc.2004.08.050
日期:2004.12
A random high-throughput screening (HTS) program to discover novel normucleoside reverse transcriptase inhibitors (NNRTIs) has been carried out with MT-4 cells against a nevirapine-resistant virus, HIV-1(IIIB-R). The primary hit, a thiazolidene-benzenesulfonamide derivative, possessed good activity. A systematic modification program examining various substituents at the 3-, 4-, and 5-positions on the thiazole ring afforded compounds with enhanced anti-HIV-1 and reverse transcriptase (RT) inhibitory activities. These results confirm the important role of the substituents at these positions and the thiazolidenebenzenesulfonamide motif as a valuable lead series for the next generation NNRTIs. (C) 2004 Elsevier Ltd. All rights reserved.